years and older. 1 – 3 Nodules are even more prevalent when the thyroid gland is examined at autopsy or surgery, or when using ultrasonography, and 50% of these have nodules, which are almost always benign. 2 , 4 New nodules develop at a rate of
Search Results
R. Michael Tuttle, Douglas W. Ball, David Byrd, Raza A. Dilawari, Gerard M. Doherty, Quan-Yang Duh, Hormoz Ehya, William B. Farrar, Robert I. Haddad, Fouad Kandeel, Richard T. Kloos, Peter Kopp, Dominick M. Lamonica, Thom R. Loree, William M. Lydiatt, Judith C. McCaffrey, John A. Olson Jr., Lee Parks, John A. Ridge, Jatin P. Shah, Steven I. Sherman, Cord Sturgeon, Steven G. Waguespack, Thomas N. Wang, and Lori J. Wirth
Saber Amin, Michael Baine, Jane Meza, and Chi Lin
, with a median survival time of 4 to 16 months, depending on the primary site. 4 – 6 Current treatment modalities available for the treatment of BMs are surgery, whole-brain radiation therapy (RT), and stereotactic radiosurgery (SRS). 7 , 8 The most
vivo tumor cellularity. Patients are evaluated for surgery 6 weeks after chemoradiotherapy. Patients with resectable disease proceed to surgery; those with unresectable disease may receive oral vorinostat once daily and oral capecitabine twice daily
Frank Qian Zhan, Vathani Sharon Packianathan, and Nathalie Charlotte Zeitouni
. Comparison of Mohs micrographic surgery and wide excision in eighty-six patients . Dermatol Surg 1997 ; 23 : 929 – 933 . 66 Boyer JD Zitelli JA Brodland DG D’Angelo G . Local control of primary Merkel cell carcinoma: review of 45 cases treated
Ang Li, Qian Wu, Suhong Luo, Greg S. Warnick, Neil A. Zakai, Edward N. Libby, Brian F. Gage, David A. Garcia, Gary H. Lyman, and Kristen M. Sanfilippo
, diabetes, hypertension, renal disease, liver disease, immobilization (paralysis/hemiplegia), blood clotting disorders (coagulopathy), anemia, history of VTE, history of bleeding, central venous catheter, recent sepsis, surgery, and traumatic injury were
Jeffrey S. Dome, Elizabeth A. Mullen, David B. Dix, Eric J. Gratias, Peter F. Ehrlich, Najat C. Daw, James I. Geller, Murali Chintagumpala, Geetika Khanna, John A. Kalapurakal, Lindsay A. Renfro, Elizabeth J. Perlman, Paul E. Grundy, and Conrad V. Fernandez
.1%, indicating that the interventions were effective ( Table 2 ). 23 A total of 39% of patients were able to undergo bilateral nephron-sparing surgery and only 1% (n=2) became anephric; 84% of patients underwent definitive surgical treatment (partial or complete
M. Zach Koontz, Brendan M. Visser, and Pamela L. Kunz
most patients treated up to the day before surgery), and the estimated overall survival at 3 years was 84%. 15 The low response rates in this study may be a function of declaring the appropriate imaging modality or response criteria. Choi et al 16
Prashant Gabani, Emily Merfeld, Amar J. Srivastava, Ashley A. Weiner, Laura L. Ochoa, Dan Mullen, Maria A. Thomas, Julie A. Margenthaler, Amy E. Cyr, Lindsay L. Peterson, Michael J. Naughton, Cynthia Ma, and Imran Zoberi
advanced TNBC typically receive chemotherapy, surgery, and radiation therapy (RT). More recently, the concept of neoadjuvant chemotherapy (NAC) followed by surgery and RT has been introduced in women with locally advanced or palpable TNBC, 6 because TNBC
Vivek Verma, Amy C. Moreno, Waqar Haque, Penny Fang, and Steven H. Lin
Despite continual efforts to improve prognosis and decrease treatment-related toxicities, non–small cell lung cancer (NSCLC) remains a major health epidemic worldwide. NSCLC is commonly treated with upfront surgery with or without prior induction
Ami Vyas, S. Suresh Madhavan, Usha Sambamoorthi, Xiaoyun (Lucy) Pan, Michael Regier, Hannah Hazard, and Sita Kalidindi
.5 billion, the initial phase of care (12 months) following BC diagnosis represented 37% of the cost, the continuing phase of care 41%, and the last year of life accounted for 22%. BC costs are substantially higher for the initial phase of care due to surgery
